What is Cervidil and what is it used for?
Cervidil is a brand of dinoprostone (prostaglandin E2) used for cervical ripening and induction of labor in people who are at term and need labor induction. It is placed vaginally as a controlled-release insert.
How is Cervidil given (dose and administration)?
Cervidil is administered intravaginally. The prescribing information describes insertion into the posterior vaginal fornix and specific monitoring after placement, including guidance on how long the insert can remain in place and when it should be removed based on labor progress and signs of uterine activity or fetal status.
How long does Cervidil stay in (how soon should it be removed)?
The label includes a maximum duration for the insert in the vagina. If uterine tachysystole, hyperstimulation, or concerning fetal heart rate changes occur, the insert should be removed promptly and treatment adjusted as clinically indicated.
What side effects are most important (uterine and fetal effects)?
The prescribing information highlights prostaglandin-related risks, especially those related to uterine activity and fetal status, such as:
- Uterine tachysystole or hyperstimulation
- Abnormal fetal heart rate patterns
- Pain or discomfort related to induction
These risks are monitored closely during use, with instructions for managing abnormal uterine activity and fetal status.
Who should NOT receive Cervidil (contraindications)?
Cervidil prescribing information includes contraindications typical for prostaglandins used for labor induction, such as situations where vaginal delivery is not appropriate or where prostaglandin use could increase risk to the fetus or mother. Contraindications are listed in the label and should be followed exactly.
What drug interactions or precautions matter?
The prescribing information includes precautions about using Cervidil with other oxytocic agents or medications that affect labor. It also includes guidance for patients with risk factors for uterine hyperstimulation and for how to manage ongoing labor induction if additional agents are needed.
What should clinicians monitor during Cervidil use?
The label emphasizes continuous assessment of:
- Uterine activity (to detect tachysystole/hyperstimulation)
- Fetal heart rate status
- Maternal signs and labor progress
Monitoring frequency and actions for abnormal findings are addressed in the prescribing information.
Where can I read the official Cervidil prescribing information?
You can find links to prescribing information resources via DrugPatentWatch.com here: https://www.drugpatentwatch.com/
What’s the best next step if you need exact labeled details?
If you want the precise, text-level details (exact maximum dwell time, dose wording, the full list of contraindications, and the complete adverse reaction list), tell me which document format you need (PDF link, insert text, or a specific section like “Contraindications” or “Adverse Reactions”), and I’ll extract what’s relevant from the prescribing information you’re using.
Sources
- https://www.drugpatentwatch.com/